Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
Authors
Keywords
Type 2 diabetes, Rheumatoid arthritis, Hypertension, Cardiovascular diseases, Regression analysis, Body mass index, Drug therapy, Physicians
Journal
PLoS One
Volume 12, Issue 7, Pages e0181203
Publisher
Public Library of Science (PLoS)
Online
2017-07-14
DOI
10.1371/journal.pone.0181203
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic syndrome and its components among rheumatoid arthritis patients: A comprehensive updated systematic review and meta-analysis
- (2017) Jamal Hallajzadeh et al. PLoS One
- Increased Cardiovascular Events and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients: 1 Year Prospective Single Centre Study
- (2017) Piero Ruscitti et al. PLoS One
- Knowledge and perception of cardiovascular disease risk among patients with rheumatoid arthritis
- (2017) Sunjoo Boo et al. PLoS One
- EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
- (2016) R Agca et al. ANNALS OF THE RHEUMATIC DISEASES
- Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study
- (2016) Paola Cipriani et al. CLINICAL RHEUMATOLOGY
- IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?
- (2016) Roberto Giacomelli et al. Expert Review of Clinical Immunology
- Retrospective analysis of type 2 diabetes prevalence in a systemic sclerosis cohort from southern Italy: Comment on “Reduced incidence of Type 1 diabetes and Type 2 diabetes in systemic sclerosis: A nationwide cohort study” by Tseng et al., Joint Bone Spine 2016;83:307–13
- (2016) Francesco Ursini et al. JOINT BONE SPINE
- Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis
- (2016) Francesco Ursini et al. MEDICINE
- Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis
- (2016) Francesco Ursini et al. PLoS One
- Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis
- (2016) Gloria Crepaldi et al. PLoS One
- Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis
- (2016) Deborah F. van Breukelen-van der Stoep et al. RHEUMATOLOGY
- Adverse effects during the oral glucose tolerance test in post-bariatric surgery patients
- (2016) Heliana Fernanda de Albuquerque Andrade et al. Archives of Endocrinology Metabolism
- Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis
- (2016) Jaap Fransen et al. PLoS One
- Prevention of cardiovascular disease in rheumatoid arthritis
- (2015) I. Hollan et al. AUTOIMMUNITY REVIEWS
- Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a pos
- (2015) P. Ruscitti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare
- (2015) Francesco Carubbi et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- The Role of IL-1βin the Bone Loss during Rheumatic Diseases
- (2015) Piero Ruscitti et al. MEDIATORS OF INFLAMMATION
- Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis
- (2015) Francesco Ursini et al. MEDICINE
- Cardiovascular comorbidity in rheumatic diseases
- (2015) Michael T. Nurmohamed et al. Nature Reviews Rheumatology
- Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events
- (2015) D. H. Solomon et al. Arthritis & Rheumatology
- The Impact of Traditional Cardiovascular Risk Factors on Cardiovascular Outcomes in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
- (2015) Leena R. Baghdadi et al. PLoS One
- The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients
- (2014) Elke E A Arts et al. ANNALS OF THE RHEUMATIC DISEASES
- Methotrexate in Rheumatoid Arthritis: Optimizing Therapy Among Different Formulations. Current and Emerging Paradigms
- (2014) Paola Cipriani et al. CLINICAL THERAPEUTICS
- Methotrexate: an old new drug in autoimmune disease
- (2014) Paola Cipriani et al. Expert Review of Clinical Immunology
- Quality of life and unmet needs in patients with inflammatory arthropathies: results from the multicentre, observational RAPSODIA study
- (2014) R. Giacomelli et al. RHEUMATOLOGY
- Serum complement C3 correlates with insulin resistance in never treated psoriatic arthritis patients
- (2013) Francesco Ursini et al. CLINICAL RHEUMATOLOGY
- World Medical Association Declaration of Helsinki
- (2013) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Improvement in insulin resistance after short-term treatment with abatacept: case report and short review
- (2012) Francesco Ursini et al. CLINICAL RHEUMATOLOGY
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Prevalence, incidence and mortality of diagnosed diabetes: evidence from an Italian population-based study
- (2011) L. Monesi et al. DIABETIC MEDICINE
- Diabetes mellitus risk in rheumatoid arthritis: Reduced incidence with anti-tumor necrosis factor α therapy
- (2011) Jana l. Antohe et al. ARTHRITIS CARE & RESEARCH
- Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study
- (2011) Lena Innala et al. ARTHRITIS RESEARCH & THERAPY
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
- (2010) J. S. Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
- (2010) Daniel Aletaha et al. ARTHRITIS AND RHEUMATISM
- Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab
- (2010) Francesco Ursini et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis
- (2010) Chi Chiu Mok et al. ARTHRITIS CARE & RESEARCH
- EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
- (2009) M J L Peters et al. ANNALS OF THE RHEUMATIC DISEASES
- Prevalence of diagnosed and undiagnosed diabetes mellitus and impaired fasting glucose in Sardinia
- (2008) Sa. Muntoni et al. ACTA DIABETOLOGICA
- Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation
- (2008) V P van Halm et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of Impaired Fasting Glucose on Cardiovascular Disease
- (2008) Yamini S. Levitzky et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started